K052549

Substantially Equivalent

LEADCARE II BLOOD LEAD TESTING SYSTEM

Applicant: Esa Biosciences, Inc.
Product code: DOF
Advisory panel: Clinical Toxicology
Date received: 2005-09-16
Decision date: 2005-10-06
Decision: Substantially Equivalent
Clearance type: Special
Location: Chelmsford, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.